Search filters

List of works by Catherine S.M. Diefenbach

Advances in Therapy for Relapsed or Refractory Hodgkin Lymphoma

scientific article published on 24 January 2020

An evaluation of brentuximab vedotin as a treatment option for stage III/IV Hodgkin lymphoma

scientific article published on 05 September 2019

Author Correction: The bone marrow microenvironment at single-cell resolution

scientific article published on 01 August 2019

Brentuximab vedotin activity in diffuse large B-cell lymphoma with CD30 undetectable by visual assessment of conventional immunohistochemistry

scientific article

CART19 in Hodgkin lymphoma: are we driving the right model?

scientific article published on 01 September 2018

Checkpoint Blockade Treatment May Sensitize Hodgkin Lymphoma to Subsequent Therapy

scientific article published on 28 July 2020

Checkpoint Inhibition in Hodgkin Lymphoma: Saving the Best for Last?

scientific article

Checkpoint blockade treatment sensitises relapsed/refractory non-Hodgkin lymphoma to subsequent therapy

scientific article published on 19 May 2020

Development of highly aggressive mantle cell lymphoma after sofosbuvir treatment of hepatitis C.

scientific article published on 11 March 2016

Emerging role of carfilzomib in treatment of relapsed and refractory lymphoid neoplasms and multiple myeloma.

scientific article

Evaluation of the International Prognostic Score (IPS-7) and a Simpler Prognostic Score (IPS-3) for advanced Hodgkin lymphoma in the modern era

scientific article published on 07 September 2015

Hodgkin Lymphoma: Current Status and Clinical Trial Recommendations.

scientific article published on 31 December 2016

Hodgkin lymphoma: targeting the tumor microenvironment as a therapeutic strategy

scientific article published on August 2015

Immune targeting of the microenvironment in classical Hodgkin's lymphoma: insights for the hematologist

scientific article published on 03 May 2019

Immunity War: A Novel Therapy for Lymphoma Using T-cell Bispecific Antibodies

scientific article published on 08 June 2018

Impact of Treatment Beyond Progression with Immune Checkpoint Blockade in Hodgkin Lymphoma

scientific article published on 10 April 2020

Lysophosphatidic acid acyltransferase-beta (LPAAT-beta) is highly expressed in advanced ovarian cancer and is associated with aggressive histology and poor survival

scientific article published on 01 October 2006

Mantle cell lymphoma in relapse: the role of emerging new drugs.

scientific article published on September 2010

Microbial dysbiosis is associated with aggressive histology and adverse clinical outcome in B-cell non-Hodgkin lymphoma

Misdiagnosis of non-hodgkin lymphoma as multiple myeloma

scientific article published on 29 October 2012

Monomorphic T-cell post-transplant lymphoproliferative disorders exhibit markedly inferior outcomes compared to monomorphic B-cell post-transplant lymphoproliferative disorders

scientific article published on 01 September 2010

New Treatment Algorithms in Hodgkin Lymphoma: Too Much or Too Little?

scientific article published on 01 May 2018

New strategies in Hodgkin lymphoma: better risk profiling and novel treatments.

scientific article published on 27 February 2013

New therapeutic targets and drugs in non-Hodgkinʼs lymphoma ⬇️

scientific article published on July 1, 2011

Peripheral T-cell lymphoma: time for a T-cell-centric standard of care

scientific article

Phase 1 study of the PI3Kδ inhibitor INCB040093 ± JAK1 inhibitor itacitinib in relapsed/refractory B-cell lymphoma

scientific article

Phase I Study of the Novel Investigational NEDD8-Activating Enzyme Inhibitor Pevonedistat (MLN4924) in Patients with Relapsed/Refractory Multiple Myeloma or Lymphoma

scientific article

Polatuzumab vedotin or pinatuzumab vedotin plus rituximab in patients with relapsed or refractory non-Hodgkin lymphoma: final results from a phase 2 randomised study (ROMULUS)

scientific article published on 29 March 2019

Potentially inappropriate medication use in elderly non-Hodgkin lymphoma patients is associated with reduced survival and increased toxicities.

scientific article

Preoperative serum YKL-40 is a marker for detection and prognosis of endometrial cancer

article

Relapsed Hodgkin lymphoma: management strategies

scientific article published on September 2014

Role of anthracycline and comprehensive geriatric assessment for elderly patients with diffuse large B-cell lymphoma.

scientific article published on 16 August 2017

Safety and immunogenicity study of NY-ESO-1b peptide and montanide ISA-51 vaccination of patients with epithelial ovarian cancer in high-risk first remission.

scientific article published in May 2008

Survival Outcomes of Younger Patients With Mantle Cell Lymphoma Treated in the Rituximab Era

scientific article published on 07 January 2019

Targeting CD30 in hodgkin lymphoma: antibody-drug conjugates make a difference

scientific article published on 01 January 2012

The bone marrow microenvironment at single-cell resolution

scientific article published on 10 April 2019

XII. Hodgkin lymphoma in older patients: challenges and opportunities to improve outcomes.

scientific article published on June 2013

Paulina is supported by:

About Paulina

Help